Every patient is different, but obesity commonly contributes to conditions such as: High blood pressure Prediabetes Type 2 diabetes Sleep apnea High cholesterol Knee and hip arthritis Fatty liver disease Cardiovascular disease For many patients, treating obesity is about improving overall healthnot simply losing weight
Introduction Holding a new vial of medication can bring a mix of hope and a touch of anxiety, especially when you are navigating a weight loss journey that feels deeply personal
Juglone, a novel activator of ferroptosis, induces cell death in endometrial carcinoma Ishikawa cells
As injectable therapies continue expanding across healthcare and research settings, bulk sourcing grows more relevant
All other cannabinoids (except cannabidiol) are prohibited in-competition in any amount, including natural cannabinoids (e.g., cannabigerol, cannabichromene, cannabinol, and others) and synthetic cannabimimetics (synthetic cannabinoid receptor agonists such as JHW, HU-210, K2/Spice, AB-PINACA, and many others)